Publication | Closed Access

T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study

Breast OncologyT-dm1 EfficacyMedicineImmunologyPathologyImmune Checkpoint InhibitorBreast CancerTaxane Plus PertuzumabCancer TreatmentOncologyRadiation Oncology